Daigdigan, Ronald L.
HRN: 28-62-63 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/09/2026
CEFUROXIME 1.5GM (VIAL)
07/09/2026
07/16/2026
IV
1.5G
Q8
R/O POST OP ADHESIONS
Checking Initial Appropriateness
07/09/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/09/2026
07/16/2026
IV
500mg
Q8h
R/O POST OP ADHESIONS
Checking Initial Appropriateness